Table 3.
Protease | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Observed Prevalence for Each Resistance Mutation (%) within the Viral Population of Each Study Participant | |||||||||||
Mutation | Class | MO09 | 924 | LUK06 | MO03 | LV04 | 1690 | 1931 | KA02 | CH02 | 1994 |
D30N | PI | 0 | 0 | 3.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
M46I | PI | 0 | 0 | 7.83 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
G73S | PI | 0 | 5.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |